BMI and TLC Influences Doxorubicin Epirubicin Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Breast Cancer. MKB 2022, 54 (4), 221-227. https://doi.org/10.15395/mkb.v54n4.2797.